ATLANTA, Nov. 2, 2016 /PRNewswire/ -- BIP Capital, one of the top venture capital firms in the Southeast, announced today
Venture Atlanta is now in its 16th year and has helped launch more than 350 companies and raise over $1.8 billion in funding to date. Early and venture stage companies chosen to present at the two-day conference represent the region's most innovative and promising technology businesses.
"We're proud that a number of our companies were selected to present at Venture Atlanta," said Mark Buffington, managing director of BIP Capital. "Atlanta is rapidly emerging as a world-class innovation center, and we're fortunate to be playing a leading role in the ecosystem's development. We look forward to a vibrant and productive two days at Venture Atlanta."
Selected companies within BIP Capital's portfolio include:
About BIP CapitalBIP Capital is recognized as one of the most active venture investors in the Southeast, with a focus on companies headquartered in Georgia, where 88 percent of its current portfolio calls home. Serving entrepreneurs, investors, and operators, it invests in and works to grow the emerging company ecosystem in and around its portfolio companies. BIP Capital applies experience and process to make investment decisions and operational recommendations, allowing its portfolio companies to achieve and stay on a glide path of growth. Areas of focus include Software, Healthcare IT, Digital Media, Franchise, and Ed Tech. For more information, visit www.bip-capital.com and follow BIP Capital on Twitter @BIPCapital.
Media contact:Dana CoganCarabiner Communicationsdcogan@carabinercomms.com678-372-2163
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/venture-atlanta-selects-five-bip-capital-portfolio-companies-300355745.html
SOURCE BIP Capital
Subscribe to our Free Newsletters!
Find out about travel shots or vaccination before you travel to your destination country. Travel ...
Hay fever is caused by allergy to pollen and is characterized by runny or blocked nose, sneezing, ...
Therapeutic drug monitoring is measuring drug concentrations at specific intervals in a patient's ...View All